88911-35-7

Basic information

• Product Name: [3aS,(+)]-1,3aα,4,5,6,6aα-Hexahydro-5β-hydroxy-6α-[(1E,3S)-3-hydroxy-1-octenyl]pentalene-2-pentanoic acid
• Synonyms: (+)-Isocarbacyclin;(3aS)-1,3aα,4,5,6,6aα-Hexahydro-5β-hydroxy-6α-[(E,S)-3-hydroxy-1-octenyl]-2-pentalenepentanoic acid;[3aS,(+)]-1,3aα,4,5,6,6aα-Hexahydro-5β-hydroxy-6α-[(1E,3S)-3-hydroxy-1-octenyl]pentalene-2-pentanoic acid;13,14-Didehydroisocarbacyclin;Isocarbacyclin;TEI-7165;2-Pentalenepentanoic acid, 1,3A,4,5,6,6A-hexahydro-5-hydroxy-6-(3-hydroxy-1-octenyl)-, (3as-(3A-alpha,5-beta,6-alpha(1E,3R*),6A-alpha))-
• CAS NO: 88911-35-7
• Molecular Formula: C21H34O4
• Molecular Weight: 350.49226
• Mol File: 88911-35-7.mol
• Article Data: 15

Chemical Properties

• Melting Point: 73-79°
• Boiling Point: 469.2°Cat760mmHg
• Flash Point: 151.9°C
• Appearance: /
• Density: 1.089g/cm³
• CAS DataBase Reference: [3aS,(+)]-1,3aα,4,5,6,6aα-Hexahydro-5β-hydroxy-6α-[(1E,3S)-3-hydroxy-1-octenyl]pentalene-2-pentanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: [3aS,(+)]-1,3aα,4,5,6,6aα-Hexahydro-5β-hydroxy-6α-[(1E,3S)-3-hydroxy-1-octenyl]pentalene-2-pentanoic acid(88911-35-7)
• EPA Substance Registry System: [3aS,(+)]-1,3aα,4,5,6,6aα-Hexahydro-5β-hydroxy-6α-[(1E,3S)-3-hydroxy-1-octenyl]pentalene-2-pentanoic acid(88911-35-7)

Safety Data

• Hazardous Substances Data: 88911-35-7(Hazardous Substances Data)

Upstream product

• 119008-13-8 (3aR,4R,5R,6aS)-5-Hydroxy-4-((E)-(S)-3-hydroxy-oct-1-enyl)-hexahydro-pentalen-1-one 
• 119008-14-9 (3aR,4R,5R,6aS)-5-(tert-Butyl-dimethyl-silanyloxy)-4-[(E)-(S)-3-(tert-butyl-dimethyl-silanyloxy)-oct-1-enyl]-hexahydro-pentalen-1-one 
• 118908-52-4 5-{(2R,3aR,4R,5R,6aS)-2-Benzenesulfonyl-5-(tert-butyl-dimethyl-silanyloxy)-4-[(E)-(S)-3-(tert-butyl-dimethyl-silanyloxy)-oct-1-enyl]-1-oxo-octahydro-pentalen-2-yl}-pentanoic acid methyl ester 
• 88911-32-4 5-{(1bS,3R,4R,4aS)-3-(Tetrahydro-pyran-2-yloxy)-4-[(E)-3-(tetrahydro-pyran-2-yloxy)-oct-1-enyl]-hexahydro-1-oxa-cyclopropa[a]pentalen-5a-yl}-pentanoic acid methyl ester 
• 88911-30-2 5-{(3aS,4R,5R,6aS)-1,2-Dihydroxy-5-(tetrahydro-pyran-2-yloxy)-4-[(E)-3-(tetrahydro-pyran-2-yloxy)-oct-1-enyl]-octahydro-pentalen-2-yl}-pentanoic acid methyl ester 
• 110456-27-4 (Z)-7-{(1S,2R,3R,5S)-5-Hydroxymethyl-3-(tetrahydro-pyran-2-yloxy)-2-[(E)-3-(tetrahydro-pyran-2-yloxy)-oct-1-enyl]-cyclopentyl}-hept-5-enoic acid methyl ester 
• 88911-34-6 5-[(3aR,5S,6S,6aR)-5-Hydroxy-6-((E)-(R)-3-hydroxy-oct-1-enyl)-1,3a,4,5,6,6a-hexahydro-pentalen-2-yl]-pentanoic acid methyl ester 
• 95205-50-8 5-{(3aR,5S,6S,6aR)-5-(tert-Butyl-dimethyl-silanyloxy)-6-[(E)-(R)-3-(tert-butyl-dimethyl-silanyloxy)-oct-1-enyl]-1,3a,4,5,6,6a-hexahydro-pentalen-2-yl}-pentan-1-ol 
• 95205-48-4 Acetic acid (3aR,5S,6S,6aR)-5-(tert-butyl-dimethyl-silanyloxy)-6-[(E)-(R)-3-(tert-butyl-dimethyl-silanyloxy)-oct-1-enyl]-1,3a,4,5,6,6a-hexahydro-pentalen-2-ylmethyl ester 
• 88931-51-5 isocarbacyclin 
• 110456-28-5 7-{(1S,2R,3R,5S)-5-Hydroxymethyl-3-(tetrahydro-pyran-2-yloxy)-2-[(E)-3-(tetrahydro-pyran-2-yloxy)-oct-1-enyl]-cyclopentyl}-6-oxo-heptanoic acid methyl ester 
• 110456-29-6 7-{(1R,2R,3R,5S)-5-Formyl-3-(tetrahydro-pyran-2-yloxy)-2-[(E)-3-(tetrahydro-pyran-2-yloxy)-oct-1-enyl]-cyclopentyl}-6-oxo-heptanoic acid methyl ester 
• 69170-69-0 5-[(4aS,5R,6R,7aS)-6-(Tetrahydro-pyran-2-yloxy)-5-[(E)-3-(tetrahydro-pyran-2-yloxy)-oct-1-enyl]-hexahydro-cyclopenta[c]pyran-(3E)-ylidene]-pentanoic acid methyl ester 
• 92134-31-1 methyl (1R,5S,6R,7R)-6-(3-oxo-(E)-1-octenyl)-7-tetrahydropyranyloxybicyclo<3.3.0>oct-2-ene-3-pentanoate 

Relevant articles and documents

Diastereoselective total synthesis of isocarbacyclin from L-ascorbic acid

Diastereoselective total synthesis of isocarbacyclin, which features a fused bicyclic key intermediate available from L-ascorbic acid, is described. The key intermediate was prepared in multigram quantities by the Pauson-Khand reaction of L-ascorbic acid-based (R)-4,4-diallyl-2,2-dimethyl-5- (trimethylsilyl)ethynyl-1,3-dioxolane (3), discriminating diastereotopic groups and faces of the geminal allyl substituents.

Exploration of ω-side chain addition strategies for the syntheses of isocarbacyclin and 15R-16-(m-tolyl)-17,18,19,20-tetranorisocarbacyclin

We describe alternative access to prostacyclin analogues by means of two ω-side chain addition strategies: Grignard reagent addition to an α,β-unsaturated Weinreb amide, followed by diastereoselective reduction of the corresponding enone system, and imple

Syntheses of isocarbacyclin by highly regioselective alkylation of allylic alcohols

-